Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica

Multiple Sclerosis Journal

Volumn 18, Issue 11, 2012, Pages 1541-1551

  Isobe, Noriko ^a   Yonekawa, Tomomi ^a   Matsushita, Takuya ^a   Kawano, Yuji ^b   Masaki, Katsuhisa ^a   Yoshimura, Satoshi ^a   Fichna, Jakub ^c   Chen, Shu ^c   Furmaniak, Jadwiga ^c   Smith, Bernard Rees ^c   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RSR Limited   (United Kingdom)

Author keywords

antibody; Aquaporin 4; ELISA; flow cytometry; IgG; multiple sclerosis; neuromyelitis optica

Indexed keywords

AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER; HYBRID PROTEIN; IMMUNOGLOBULIN G;

BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; MYELOOPTIC NEUROPATHY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; NEUROMYELITIS OPTICA; PREDICTIVE VALUE OF TESTS; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSFECTION;

EID: 84863988174     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512443917     Document Type: Article

References (39)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
2. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477 (Pubitemid 41186945)
3. Kira J.. Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis. Pathophysiology. 2011 ; 18: 69-79
4. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry. 2006 ; 77: 1073-1075 (Pubitemid 44338534)
5. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007 ; 130: 1206-1223 (Pubitemid 47355945)
6. Matsushita T, Isobe N, Matsuoka T, et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler. 2009 ; 15: 834-847
7. Koller H, Neuen-Jacob E, Saleh A, et al. A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings. J Neurol. 2006 ; 253: 819-820 (Pubitemid 43980160)
8. Bergamaschi R, Jarius S, Robotti M, et al. Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol. 2009 ; 256: 2097-2099
9. Nishiyama S, Ito T, Misu T, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology. 2009 ; 72: 1960-1961
10. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titer. Brain. 2007 ; 130: 1235-1243 (Pubitemid 47355956)
11. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008 ; 131: 3072-3080
12. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007 ; 4: e133
13. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008 ; 196: 181-187
14. Fazio R, Malosio ML, Lampasona V, et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler. 2009 ; 15: 1153-1163
15. Ann Neurol. Polman CH Reingold SC Edan G, ed. 2005: 840-846.
16. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 ; 53: 1107-1114 (Pubitemid 29442132)
17. Kurtzke JF.. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
18. Poser S, Ritter G, Bauer HJ, et al. HLA-antigens and the prognosis of multiple sclerosis. J Neurol. 1981 ; 225: 219-221 (Pubitemid 11070497)
19. Fukazawa T, Hamada T, Tashiro K, et al. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci. 1990 ; 100: 217-222
20. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988 ; 38: 180-185 (Pubitemid 18036832)
21. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069 (Pubitemid 27493740)
22. Brooking H, Ananieva-Jordanova R, Arnold C, et al. A sensitive non-isotopic assay for GAD65 autoantibodies. Clin Chim Acta. 2003 ; 331: 55-59 (Pubitemid 36412025)
23. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
24. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
25. Mader S, Lutterotti A, Di Pauli F, et al. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One. 2010 ; 5: e10455
26. Tanaka K, Tani T, Tanaka M, et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler. 2007 ; 13: 850-855 (Pubitemid 351540855)
27. Kalluri SR, Illes Z, Srivastava R, et al. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol. 2010 ; 67: 1201-1208
28. Wang KC, Tsai CP, Lee CL, et al. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan. Eur Neurol. 2011 ; 65: 99-104
29. Collongues N, Marignier R, Zephir H, et al. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study. Mult Scler. 2011 ; 17: 720-724
30. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
31. Pittock SJ, Lennon VA.. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008 ; 65: 629-632 (Pubitemid 351679657)
32. Kalluri SR, Rothhammer V, Staszewski O, et al. Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica. PloS One. 2011 ; 6: e16083
33. Lux A, Aschermann S, Biburger M, et al. The pro and anti-inflammatory activities of immunoglobulin G. Ann Rheum Dis. 2010 ; 69: i92 - i96
34. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology. 1995 ; 45: 1277-1285
35. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol. 1996 ; 39: 285-294 (Pubitemid 26100751)
36. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis. Lancet. 1998 ; 352: 1498-1504
37. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000 ; 343: 898-904
38. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001 ; 357: 1576-1582 (Pubitemid 32488815)
39. Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with.. :